TESTED COMPOUNDS
Aminoglycosides - streptomycin
INHIBITORY CONCENTRATION VALUES (MIC/IC50)
MIC = 0.25 µg/ml
EXPERIMENTAL TECHNIQUE
in vitro
LINK TO PUBMED
https://pubmed.ncbi.nlm.nih.gov/22143518/
MOLECULAR FORMULA
C21H39N7O12
2D STRUCTURE
MOLECULAR WEIGHT
581.6 µg/mol
PUBCHEM CID
19649
DRUG BANK ID
DB01082
REFERENCE
Ruf, M. T., Sch?tte, D., Chauffour, A., Jarlier, V., Ji, B., & Pluschke, G. (2012). Chemotherapy-Associated Changes of Histopathological Features of Mycobacterium ulcerans Lesions in a Buruli Ulcer Mouse Model. Antimicrobial Agents and Chemotherapy, 56(2), 687. https://doi.org/10.1128/AAC.05543-11 Till, F. O., Tjip, S. v., & Richard, O. P. (2019, April 30). Antimicrobial Treatment of Mycobacterium ulcerans Infection. Buruli Ulcer: Mycobacterium ulcerans Disease, pp. 12-20. Feldman WH, Karlson AG (1957) Mycobacterium ulcerans infections; response to chemotherapy in mice. Am Rev Tuberc 75(2):266?279